Published by Josh White on 27th August 2024
(Sharecast News) - Diaceutics announced a significant enhancement to its rare-disease offerings on Tuesday, leading to the acquisition of a new contract aimed at supporting the commercialisation of a rare-disease therapy.
URL: http://www.digitallook.com/dl/news/story/34515084/...